Completed OBSERVATIONAL NCT07127315
Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy
A Prospective Study Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy
Sponsor: Helwan University
Conditions
Breast Cancer Chemotherapy Gonadotropin Releasing Hormone Agonists Ovarian Function Premenopausal
Interventions
Chemotherapy Gonadotropin-releasing hormone agonist
Updated 1 time since 2025 Last updated: Aug 10, 2025 Started: Jul 1, 2022 Primary completion: Jun 1, 2024 Completion: Jul 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07127315, this observational or N/A phase trial focuses on Breast Cancer and Chemotherapy and remains completed. Sponsored by Helwan University, it has been updated 1 time since 2022, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
1 version recorded Completed
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Helwan University
Data source: Helwan University
For direct contact, visit the study record on ClinicalTrials.gov .